The pandemic has been transformational for many businesses, but few can boast near-global domination the way Pfizer (PFE) can. The Pfizer/BioNTech (BNTX) vaccine accounts for 70% of all doses in the U.S. and E.U., as of February 5, according to CEO Albert Bourla Tuesday.
He added that the vaccine and other Pfizer medicines reached 1.4 billion patients in 2021, or about one in six people on Earth.
As a result, the company saw a 92% increase in operational revenue growth in 2021 alone, of which…
Source link
